Metabolic profiling of tyrosine kinase inhibitor nintedanib using metabolomics
This study provided a global view of nintedanib metabolism, which could be used to understand the mechanism of adverse effects related to nintedanib and its potential drug-drug interaction.
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Drugs & Pharmacology | Heart | Liver | Men | Study | Toxicology | Urology & Nephrology